Image source: Shutterstock
Highlights
- Medibank provides health insurance, life, pet, and travel insurance and is committed to reducing carbon emissions and achieving Net Zero.
- 64% of electricity of MPL came from renewable sources as of June 2024; it targets 100% renewable energy by 2025.
- The company targets 100% reduction in carbon emissions by 2025.
- MPL plans to invest AUD 150–250 million in M&A to drive inorganic growth.
Medibank Private Limited (ASX:MPL) is a private health insurance and health solutions company that also offers other types of insurance, including life, pet, and travel insurance, to provide ease to its customers. The company is committed to reducing carbon emissions across its operations and accelerating its Net Zero Pathway.
Sustainability Initiatives of MPL
- Introduction of hybrid vehicles: The Mobile Amplar Health team at MPL has begun replacing petrol vehicles with hybrid vehicles.
- Renewable energy: As of June 2024, 64% of the MPL’s electricity came from renewable sources. The company targets 100% renewable energy usage by 2025.
- Energy-efficient infrastructure: A 6-star Green Star office was opened in Melbourne, with the office design aligning with the Net Zero goal.
- Environmentally friendly healthcare models: The company offers virtual healthcare, significantly reducing environmental impact. Additionally, homecare services cut down the environmental burden of hospital stays, such as water and electricity usage.
By 2025, the company targets a 100% reduction in carbon emissions.
Financial Performance of MPL in FY24
In the financial year 2024 (FY24), MPL’s revenue increased by nearly 4.7% to AUD 8,175.8 million, and NPAT attributable to shareholders jumped 59.6% year-on-year (YoY) to AUD 492.5 million. Meanwhile, the operating profit of MPL grew by 7.9% YoY to AUD 699.8 million, with the health insurance segment recording a 6.3% YoY rise in operating profit and Medibank Health reporting a surge of 36.7% YoY.
Outlook
In FY25, moderate industry growth is anticipated compared to FY24, and the company intends to grow in line with market trends while increasing its market share. During the reported period, the company expects policy unit growth to continue, with expected claims per policy unit increasing by nearly 2.7%. Productivity savings of AUD 10 million are targeted for FY25.
Between FY24 and FY26, the company aims to achieve an average annual organic profit growth of 15% or more, including a 12-month contribution from Myhealth in FY25. Furthermore, MPL plans to invest AUD 150–250 million in mergers and acquisitions during the period to achieve inorganic growth.
Share Performance of MPL
MPL shares closed 1.069% lower at AUD 3.70 apiece, with a market cap of AUD 10.29 billion, on 22 November 2024. Over the last year, MPL’s share price increased by 5.11%, but in the last three months, it has dropped by around 6.09%.
52-week high for MPL is AUD 4.01, recorded on 3 September 2024, and 52-week low is AUD 3.40, recorded on 30 November 2023.

MPL Daily Technical Chart, Source: REFINITIV
Note 1: Past performance is neither an Indicator nor a guarantee of future performance.
Note 2: The reference date for all price data, and currency, is 22 November 2024. The reference data in this report has been partly sourced from REFINITIV.
Disclaimer:
This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.
Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.
There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.
Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.
The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.
The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.
Kalkine does not issue, sell or deal in any financial products.
This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.
To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.
Please also read our Terms & Conditions and Financial Services Guide for further information.
Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.
Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.
Copyright 2026 Krish Capital Pty. Ltd. (ABN 61629651510). All Rights Reserved. No part of this Article, or its content, may be reproduced in any form without our prior consent.